NC3Rs microsites


Partnership microsites




New report on the NC3Rs collaboration with the pharmaceutical industry published

Launched at an event in the House of Lords, the report describes how data sharing and open innovation programmes led by the NC3Rs are supporting 3Rs advances in drug discovery and development.

Find out more...

Working together to CRACK dementia

NC3Rs collaborate with Alzheimer's Research UK to fund the development of new tests for evaluating potential dementia drugs, which could reduce reliance on animal use and accelerate the drug development pipeline

Find out more...

Replacing animal models for studying bovine TB

With support of 2 million from the BBSRC, the NC3Rs is announcing at a London meeting on 8 July a Strategic Award call to generate new models for bovine Tuberculosis (bTB) research that avoid the use of animals.

Find out more...

Competition winners announced

NC3Rs joins forces with other funding bodies to dedicate 4m to advancing non-animal technology development

Find out more...


Centre News

1.5m invested in imaging technology development
Five grants co-funded with the EPSRC aim to reduce animal use in preclinical research.

NC3Rs Public Engagement Award winners announced
New funding encourages NC3Rs researchers to talk about their work.

Three David Sainsbury Fellowships awarded
Supporting junior scientists working to discover new ways of applying the 3Rs.

NC3Rs e-newsletter - July 2014
Working with the pharmaceutical industry, funding the next generation of scientists, and encouraging our researchers to talk about their work to the public.


About Us

The National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs) leads on the discovery and application of new technologies and approaches to minimise the use of animals and improve animal welfare (the 3Rs). We fund research, support training and development, and stimulate changes in regulations and practice. Primarily funded by Government, the NC3Rs is also supported by the charitable and private sectors.


  • Twitter
  • Facebook
  • LinkedIn
  • RSS Feed
  • Email